Publicaciones (107) Publicaciones de Raúl de Pablo Sánchez

2024

  1. Ceftaroline fosamil treatment patterns and outcomes in adults with community-acquired pneumonia: a real-world multinational, retrospective study

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  2. The ICU environment contributes to the endemicity of the "Serratia marcescens complex" in the hospital setting

    mBio, Vol. 15, Núm. 5, pp. e0305423

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Early routine use of V-A ECMO in patients with myocardial infarction and cardiogenic shock, is it a poor choice?

    Medicina Intensiva

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. How and when should a CO2 removal device be used?

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 45-47

  5. Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain

    Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 5, pp. 1259-1264

  6. Reply to “Pulmonary aspergillosis in the intensive care unit: An underdiagnosed disease?”

    Medicina Intensiva

  7. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 5, pp. 465-476

2022

  1. Altered Ecology of the Respiratory Tract Microbiome and Nosocomial Pneumonia

    Frontiers in Microbiology, Vol. 12

  2. Benefit with preventive noninvasive ventilation in subgroups of patients at high-risk for reintubation: a post hoc analysis

    Journal of Intensive Care, Vol. 10, Núm. 1

  3. Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

    Intensive Care Medicine, Vol. 48, Núm. 6, pp. 690-705

  4. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set

    Critical Care, Vol. 26, Núm. 1

  5. Compassionate use of cefiderocol to treat tissue infection caused by MDR-pseudomonas aeruginosa in a critically-ill patient

    Revista Chilena de Anestesia, Vol. 51, Núm. 2, pp. 213-216

  6. Correction to: Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study (Intensive Care Medicine, (2022), 48, 6, (690-705), 10.1007/s00134-022-06705-1)

    Intensive Care Medicine

  7. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set (Critical Care, (2022), 26, 1, (236), 10.1186/s13054-022-04108-8)

    Critical Care

  8. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  9. Diarrea crónica y parada cardiorrespiratoria

    Colección de casos clínicos cerrados de la Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá (2020-2021) (Servicio de Publicaciones), pp. 165-179

  10. Early Tracheostomy for Managing ICU Capacity During the COVID-19 Outbreak: A Propensity-Matched Cohort Study

    Chest, Vol. 161, Núm. 1, pp. 121-129

  11. Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

    The Lancet Global Health, Vol. 10, Núm. 2, pp. e227-e235